- 12.28.2023
- Updates
- Press Releases
PRESS RELEASE: VETS and Rep. Dan Crenshaw Celebrate Bi-Partisan Support for NDAA Bill that Includes Grants for Research in Psychedelic Treatment
Collaboration Helps Bring U.S. Rep. Dan Crenshaw's Douglas Mike Day Psychedelic Therapy to Save Lives Act, legislation that will direct the Defense Department to create grants for studying psychedelic treatments for active duty service members.
- 12.21.2023
- Updates
MDMA therapy for wartrauma in civilians and veterans, by Amber Capone & Johnathan M. Lubecky
The discussion highlights VETS' mission and the advocacy work of Amber, Jon, and the full team to advance research and access for veterans to receive PAT (MDMA and ibogaine).
- 12.18.2023
- Updates
Military Times: First-ever provision for psychedelic studies included in defense bill
A first-ever provision included in this year’s defense policy bill enables studies to analyze the effects of psychedelics on troops suffering from various medical issues.
THE INTERCEPT: CONGRESS IS PUSHING REVOLUTIONARY RESEARCH ON PSYCHEDELIC TREATMENTS FOR THE MILITARY
A provision in the annual defense bill would have the Pentagon run clinical trials for members of the military with post-traumatic stress disorder.
- 12.5.2023
- Updates
OAN: VETS Advocate For Psychedelic-Assisted Therapies
The non-profit Veterans Exploring Treatment Solutions organization is taking a unique approach to combat veteran suicides through psychedelic-assisted therapies. One America’s Stephanie Myers speaks with the organization’s co-founder, Amber Capone, about her inspiration and determination to create the non-profit.
- 11.30.2023
- Updates
DAV: VETERANS AND THE NEW PSYCHEDELIC RENAISSANCE
The consuming grip of suicidal thoughts had become so dark that, in 2015, Marine veteran Justin Carlisle nearly took his life. The Iraq War veteran was desperate to try something that could offer some relief from his wartime trauma and waning mental health. That’s when a friend suggested ayahuasca.
- 11.27.2023
- Updates
High Times: U.S. Military Veterans Are Going to Mexico for Psychedelic Treatment
A recent report by CBS News highlighted this trend, noting that as “ many veterans with PTSD remain desperate for healing, a growing number are turning to psychedelic-assisted treatment in Mexico — using substances the government they fought for says are illegal.”
- 11.16.2023
- Updates
CBS News: U.S. military veterans turn to psychedelics in Mexico for PTSD treatment
Suicide rates for American service members and veterans are nothing short of catastrophic, with recent estimates claiming almost 17 vets take their own lives in the U.S. every day. Many of them suffer from post-traumatic stress and debilitating brain injuries, which traditional medications have largely failed to cure.
- 11.16.2023
- Updates
Stars and Stripes: Ecstasy and magic mushrooms show signs of helping with PTSD treatment, researchers say
Researchers and veterans testifying Tuesday on the use of psychedelic drugs to relieve post-traumatic stress disorder and suicidal thoughts urged House lawmakers to back more studies into the alternative treatments.
- 11.8.2023
- Updates
Newsweek: The Case for Ibogaine: Kentucky's Opportunity to Lead in the Fight Against Opioid Addiction | Opinion
As the opioid epidemic continues to grip our nation, claiming lives, destroying families, and burdening communities, it is imperative that we explore every viable solution. Among these potential solutions is a powerful, natural, non-addictive substance known as ibogaine. As voices that have served in political and military capacities, we unite in our appeal to the Kentucky Opioid Abatement Advisory Commission (KYOAAC): Allocate $42 million for ibogaine research. Kentucky has a unique chance to pioneer a revolutionary approach to combat opioid addiction and pave the way for the entire country.